Electrodiagnostic criteria for Guillain-Barrè syndrome: A critical revision and the need for an update

Clinical Neurophysiology

Volumn 123, Issue 8, 2012, Pages 1487-1495

  Uncini, Antonino ^a   Kuwabara, Satoshi ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Acute motor and sensory axonal neuropathy; Acute motor axonal neuropathy; Conduction block; Electrodiagnostic criteria; Guillain Barr syndrome; Reversible conduction failure

Indexed keywords

ACUTE MOTOR AXONAL NEUROPATHY; CLINICAL FEATURE; DEMYELINATING NEUROPATHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTRODIAGNOSIS; GUILLAIN BARRE SYNDROME; HUMAN; NERVE CONDUCTION DISORDER; NERVE FIBER DEGENERATION; PARAMETERS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYNDROME DELINEATION;

ELECTRODIAGNOSIS; GUILLAIN-BARRE SYNDROME; HUMANS; MOTOR NEURONS; NERVE DEGENERATION; NEURAL CONDUCTION;

EID: 84863212923     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2012.01.025     Document Type: Review

References (78)

1. Ad Hoc Subcommitte of the American Academy of Neurology AIDS Task Force Research Criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 1991, 41:617-618.
2. Alam T.A., Chaudhry V., Cornblath D.R. Electrophysiological studies in the Guillain-Barré syndrome: distinguishing subtypes by published criteria. Muscle Nerve 1998, 2:1275-1279.
3. Arnason B.G.W., Soliven B. Acute inflammatory demyelinating polyradiculoneuropathy. Peripheral neuropathy 1993, 1437-1479. WB Saunders, Philadelphia. 3rd ed. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, J.F. Poduslo (Eds.).
4. Albers J.W., Donofrio P.D., McGonagle T.K. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy. Muscle Nerve 1985, 8:528-539.
5. Asbury A.K., Arnason B.G., Adams R.D. The inflammatory lesions in idiopathic polyneuritis: its role in pathogenesis. Medicine 1969, 48:173-215.
6. Asbury A.K., Arnason B.G., Karp H.R., McFarlin D.E. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978, 3:565-566.
7. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990, 27(Suppl):S21-S24.
8. Boërio-Guéguen D., Ahdab R., Ayache S.S., Kerschen P., André C., Créange A., et al. Distal nerve excitability and conduction studies in a case of rapidly regressive acute motor neuropathy with multiple motor conduction blocks. J Peripher Nerv Syst 2010, 15:369-372.
9. Bostock H., Burke D., Hales J.P. Differences in behaviour of sensory and motor axons following release of ischemia. Brain 1994, 117:225-234.
10. Brown W.F., Feasby T.E., Hahn A.F. The electrophysiological changes in the acute " axonal" form of Guillain-Barré syndrome. Muscle Nerve 1993, 16:200-205.
11. Capasso M., Caporale C.M., Pomilio F., Gandolfi P., Lugaresi A., Uncini A. Acute motor conduction block neuropathy: another Guillain-Barré syndrome variant. Neurology 2003, 61:617-622.
12. Capasso M., Notturno F., Manzoli C., Yuki N., Uncini A. Reversible conduction failure in pharingeal-cervical-brachial variant of Guillain-Barré syndrome. Muscle Nerve 2010, 42:608-6012.
13. Capasso M., Notturno F., Manzoli C., Uncini A. Involvement of sensoryfibers in axonal subtypes of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2011, 82:664-670.
14. Caporale C.M., Capasso M., Luciani M., Prencipe V., Creati B., Gandolfi P., et al. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome. J Neuroimmunol 2006, 174:12-20.
15. Cleland J.C., Malik K., Thaisetthawatkul P., Herrmann D.N., Logigian E.L. Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed distal compound muscle action potential to electrodiagnosis. Muscle Nerve 2006, 33:771-777.
16. Corcia P., Beaume A., Guennoc A.M., de Toffol B., Preud'homme J.L., Autret A. Acute demyelinating motor neuropathy: an atypical form of the Guillain-Barré syndrome?. Rev Neurol (Paris) 1999, 155:596-597.
17. Cornblath D.R. Electrophysiology in Guillain-Barré syndrome. Ann Neurol 1990, 27(suppl):S517-S520.
18. Cornblath D.R., Kuncl R.W., Mellits E.D., Quaskey S.A., Clawson L., Pestronk A., et al. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 1992, 15:1111-1115.
19. Cornblath D.R., Sumner A.J. Conduction block in neuropathies with necrotizing vasculitis. Muscle Nerve 1991, 14:184-185.
20. De Angelis M.V., Di Muzio A., Lupo S., Gambi D., Uncini A., Lugaresi A. Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier. J Neuroimmunol 2001, 121:79-82.
21. Feasby T.E., Gilbert J.J., Brown W.F., Bolton C.F., Hahn A.F., Koopman W.F. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986, 109:1115-1126.
22. Feasby T.E., Hahn A.F., Brown W.F., Bolton C.F., Gilbert J.J., Koopman W.F. Severe degeneration in acute Guillain-Barré syndrome evidence of two different mechanisms. J Neurol Sci 1993, 116:185-192.
23. Griffin J.W., Li C.Y., Ho T.W., Xue P., Macko C., Gao C.Y., et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995, 118:577-595.
24. Griffin J.W., Li C.Y., Macko C., Ho T.W., Hsieh S.T., Xue P., et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol 1996, 25:33-51.
25. Griffin J.W., Li C.Y., Ho T.W., Tian M., Gao C.Y., Xue P., et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996, 39:17-28.
26. Guillain G., Barré J.A., Strohl A. Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalorachidien sans réaction cellulaire: remarques sur les caractères cliniques et graphiques des reflexestendinex. Bull Soc Med Hop Paris 1916, 40:1462-1470.
27. Hadden R.D., Cornblath D.R., Hughes R.A.C., Zielasek J., Hartung H.P., Toyka K.V., et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998, 44:780-788.
28. Hafer-Macko C., Hsieh S.-T., Li C.Y., Ho T.W., Sheikh K., Cornblath D.R., et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996, 40:635-644.
29. Hiraga A., Kuwabara S., Ogawara K., Misawa S., Kanesaka T., Koga M., et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome. Neurology 2005, 64:856-860.
30. Hiraga A., Mori M., Ogawara K., Kojima S., Kanesaka T., Misawa S., et al. Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2005, 76:719-722.
31. Hughes R.A.C., Rees J.H. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997, 176(Suppl 2):S92-S98.
32. Ho T.W., Mishu B., Li C.Y., Gao C.Y., Cornblath D.R., Griffin J.W., et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995, 118:597-605.
33. Ho T.W., Willison H.J., Nachamkin I., Li C.Y., Veitch J., Ung H., et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol 1999, 45:168-173.
34. Hong Y.N., Sung J.J., Oh M.Y., Moon H.J., Park K.S., Lee K.W. Axonal conduction block at intermediate nerve segments in pure motor Guillain-Barré syndrome. J Peripher Nerv Syst 2011, 16:37-46.
35. Islam Z., Jacobs B.C., van Belkum A., Mohammad Q.D., Islam M.B., Herbrink P., et al. Axonal variant of Guillain-Barré syndromeafter Campylobacter infection in Bangladesh. Neurology 2010, 74:581-587.
36. Kalita J., Misra U.K., Das M. Neurophysiologic criteria in the diagnosis of different clinical types of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2008, 79:289-293.
37. Kaida K., Sonoo M., Ogawa G., Kamakura K., Ueda-Sada M., Arita M., et al. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barré syndrome. Neurology 2008, 71:1683-1690.
38. Kiernan M.C., Mogyoros I., Burke D. Differences in recovery cycle of excitability in sensory and motor axons of human median nerve. Brain 1996, 119:1099-1105.
39. Kokubun N., Nishibayashi M., Uncini A., Odaka M., Hirata K., Yuki N. Conduction block in acute motor axonal neuropathy. Brain 2010, 133:2897-2908.
40. Kushnir M., Klein C., Pollak L., Rabey J.M. Evolving pattern of Guillain-Barré syndrome in a community hospital in Israel. Acta Neurol Scand 2008, 117:347-350.
41. Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 1998, 44:202-208.
42. Kuwabara S., Mori M., Ogawara K., Hattori T., Yuki N. Indicators of rapid clinical recovery in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2001, 70:560-562.
43. Kuwabara S., Ogawara K., Misawa S., Mizobuchi K., Sung J.Y., Kitano Y. Sensory nerve conduction in demyelinating and axonal Guillain-Barré syndromes. Eur Neurol 2004, 51:196-198.
44. Kuwabara S. Guillain-Barré syndrome. Curr Neurol Neurosci Rep 2007, 7:57-62.
45. Kuwabara S. Axonal Guillain-Barré syndrome is underestimated in Europe?. J Neurol Neurosurg Psychiatry 2010, 81:1063.
46. Lambert E.H., Mulder D.W. Nerve conduction in the Guillain-Barré syndrome. Bull Am Assoc Electromyogr Electrodiagn 1963, 10:13.
47. Lopez P.H., Zhang G., Bianchet M., Schnaar R.L., Sheikh K.A. Structural requirements of anti-GD1a antibodies determine their target specificity. Brain 2008, 131:1926-1939.
48. Lin C.S., Kuwabara S., Cappelen-Smith C., Burke D. Responses of human sensory and motor axons to the release of ischaemia and to hyperpolarizing currents. J Physiol 2002, 541:1025-1039.
49. Lugaresi A., Ragno M., Torrieri F., Di Guglielmo G., Fermani P., Uncini A. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis. J Neurol Sci 1997, 147:193-200.
50. McGonical R., Rowen E.G., Greenshilds K.N., Halstead S.K., Humphreys P.D., Rother R.P., et al. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 2010, 133:1944-1960.
51. McCluskey L., Feinberg D., Cantor C., Bird S. Pseudo-conduction block in vasculitic neuropathy. Muscle Nerve 1999, 10:1361-1366.
52. McKhann G.M., Cornblath D.R., Griffin J.W., Ho T.W., Li C.Y., Jiang Z., et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993, 33:333-342.
53. Mogyoros I., Kiernan M.C., Burke D. Strength-duration properties of human peripheral nerve. Brain 1996, 119:439-447.
54. Nachamkin I., Arzarte Barbosa P., Ung H., Lobato C., Gonzalez Rivera A., Rodriguez P., et al. Patterns of Guillain-Barré syndrome in children. Results from a Mexican population. Neurology 2007, 69:1665-1671.
55. Notturno F., Caporale C.M., Uncini A. Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery. Muscle Nerve 2008, 37:265-268.
56. Ogawa G., Kaida K., Shiozaki Y., Araki M., Kimura F., Kamakura K. Case of pure motor Guillain-Barré syndrome with motor conduction block andanti-GM1/GalNAc-GD1a antibody. Rinsho Shinkeigaku 2009, 49:488-492.
57. Ogawara K., Kuwabara S., Mori M., Hattori T., Koga M., Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000, 48:624-631.
58. Osler L.D., Sidell A.D. The Guillain-Barré syndrome: the need for exact diagnostic criteria. N Engl J Med 1960, 262:964-969.
59. Rajabally Y.A., Strens L.H.A., Abbott R.J. Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery. Neurology 2006, 66:287-288.
60. Rajabally Y.A., Hassan-Smith G., Notturno F., Eames P.J., Hayton T., Capasso M., et al. Motor and sensory conduction failure in overlap of Guillain-Barré syndrome and Miller Fisher syndrome: two simultaneous cases. J Neurol Sci 2011, 303:35-38.
61. Rees J.H., Gregson N.A., Hughes R.A.C. Anti-ganglioside GM1 antibody in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995, 38:809-816.
62. Sekiguchi Y., Uncini A., Yuki N., Misawa S., Notturno F., Nasu S., et al. Anti-ganglioside antibodies are associated with axonal Guillain-Barré syndrome. A Japanese-Italian collaborative study. J Neurol Neurosurg Psychiatry 2012, 83:23-28.
63. Shafquat S., Khealani A., Awan F., Abedin E. Guillain-Barré syndrome in Pakistan: similarity of demyelinating and axonal variants. Eur J Neurol 2006, 13:662-665.
64. Sugie K., Murata K., Ikoma K., Suzumura A., Takayanagi T. A case of acute multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis. Rinsho Shinkeigaku 1998, 38:42-45.
65. Susuki K., Rasband M.N., Tohyama K., Koibuchi K., Okamoto S., Funakoshi K., et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007, 27:3956-3967.
66. Susuki K., Johkura K., Yuki N., Hasegawa O., Kuroiwa Y. Rapid resolution of nerve conduction blocks after plasmapheresis in Guillain-Barré syndrome associated with anti-GM1b IgG antibody. J Neurol 2001, 248:148-150.
67. Uncini A., Capasso M. Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery. Neurology 2006, 67:543.
68. Uncini A., Yuki N. Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes. Expert Rev Neurother 2009, 9:869-884.
69. Uncini A., Manzoli C., Notturno F., Capasso M. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 2010, 81:1157-1163.
70. Van der Meché F.G.A., Meulstee J., Vermeulen M., Kievit A. Patterns of conduction failure in the Guillain-Barré syndrome. Brain 1988, 111:405-416.
71. Van Asseldonk J.T., Van den Berg L.H., Kalmijn S., Wokke J.H., Franssen H. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Brain 2005, 128:880-891.
72. Van der Meché F.G.A., Meulstee J., Kleyweg R.P. Axonal damage in Guillain-Barré syndrome. Muscle Nerve 1991, 14:997-1002.
73. Vucic S., Cairns K.D., Black K.R., Chong P.S., Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clin Neurophysiol 2004, 115:2329-2335.
74. White J.R., Sachs G.M., Gilchrist J.M. Multifocal motor neuropathy with conduction block and Campylobacter jejuni. Neurology 1996, 46:562-563.
75. Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990, 40:1900-1902.
76. Yuki N., Kuwabara S., Koga M., Hirata K. Acute motor axonal neuropathy and acute motor-sensory neuropathy share a common immunological profile. J Neurol Sci 1999, 168:121-126.
77. Yuki N., Yamada M., Koga M., Odaka M., Susuki K., Tagawa Y., et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001, 49:712-720.
78. Yuki N., Sususki K., Koga M. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci 2004, 101:1140-1149.